UBS Group’s Hyperfine HYPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.5K Buy
37,484
+1,883
+5% +$2.14K ﹤0.01% 7511
2025
Q4
$34.9K Buy
35,601
+32,759
+1,153% +$39.5K ﹤0.01% 7436
2025
Q3
$4.12K Sell
2,842
-4,059
-59% -$4.74K ﹤0.01% 8970
2025
Q2
$4.97K Sell
6,901
-4,991
-42% -$3.5K ﹤0.01% 9223
2025
Q1
$8.51K Sell
11,892
-18,220
-61% -$18.7K ﹤0.01% 8750
2024
Q4
$26.5K Buy
30,112
+21,120
+235% +$20.3K ﹤0.01% 7697
2024
Q3
$9.71K Sell
8,992
-12,613
-58% -$13.4K ﹤0.01% 7775
2024
Q2
$18.4K Buy
21,605
+10,882
+101% +$9.54K ﹤0.01% 7349
2024
Q1
$10.7K Buy
10,723
+9,479
+762% +$10.2K ﹤0.01% 7212
2023
Q4
$1.39K Buy
1,244
+1,005
+421% +$1.4K ﹤0.01% 8316
2023
Q3
$490 Buy
239
+38
+19% +$88 ﹤0.01% 8459
2023
Q2
$432 Sell
201
-5,006
-96% -$8.16K ﹤0.01% 8237
2023
Q1
$7.5K Sell
5,207
-7,771
-60% -$9.51K ﹤0.01% 7800
2022
Q4
$10.9K Buy
12,978
+12,777
+6,357% +$11.6K ﹤0.01% 8458
2022
Q3
$0 Sell
201
-766
-79% -$1.08K ﹤0.01% 10593
2022
Q2
$2K Buy
967
+116
+14% +$342 ﹤0.01% 9564
2022
Q1
$3K Buy
851
+559
+191% +$2.31K ﹤0.01% 9447
2021
Q4
$2K Buy
+292
New +$2.31K ﹤0.01% 9801

Other funds holding HYPR

UBS Group's HYPR Position: Q1 2026 in Review

UBS Group increased its Hyperfine (HYPR) stake by 5.3% in Q1 2026, buying an estimated $2.14K and bringing the position to 37,484 shares worth $40.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7511.

UBS Group first reported a position in HYPR in Q4 2021 and has held it in 18 quarters since. 50 funds tracked by Wall St. Rank hold HYPR as of Q1 2026.

  • UBS Group held 37,484 shares of Hyperfine worth $40.5K as of Q1 2026.
  • UBS Group bought 1,883 Hyperfine shares in Q1 2026, an estimated $2.14K.
  • Hyperfine made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7511 holding.
  • UBS Group first reported a position in Hyperfine in Q4 2021 and has held it in 18 quarters since.
  • 50 funds tracked by Wall St. Rank held Hyperfine as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.